Translation
Notice: This document is a translation of the original Japanese document and is for reference purposes only. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Alfresa Holdings Corporation
May 18, 2026
Notice of the Result and Completion of the Acquisition of Own Shares through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3)Alfresa Holdings Corporation (the "Company") hereby announces that the acquisition of treasury shares (the "Acquisition") announced on May 15, 2026 has been executed as follows. The Company also announcesthatthe Acquisitionhasbeencompletedasresolvedatthe Board of Directors meetingand announced on May 15,2026. In addition,as a result of the Acquisition, termsofthe1stissuanceofstockacquisitionrightviathird-partyallotmentbasedonaresolution at the Board of Directors meeting on May 15, 2026 has been finalized. For details, please refer to the Company's press release entitled "Notice on the Decision of Terms of the 1st Issuance of Stock Acquisition Right via Third-Party Allotment for Acquisition of Own Shares via Fully Committed Share Repurchase (Japanese ASR)" dated May 18, 2026.
-
Reason for the Treasury Share Acquisition
As part of our commitment to a flexible capital policy, we repurchased treasury stock to drive capital efficiency and enrich shareholder returns in light of the current business climate.
- Overview of the Acquisition
(1) | Type of stock acquired | Common stock |
(2) | Total number of shares acquired | 6,307,800 shares (3.5% of the total number of shares outstanding, excluding treasury shares) |
(3) | Total acquisition value of shares | JPY14,999,948,400 |
(4) | Acquisition date | May 18, 2026 |
(5) | Acquisition method | Purchase via Tokyo Stock Exchange off-auction own share repurchase trading system (ToSTNeT-3) |
(Note) 2,208,100 shares out of the number of shares in (2) above were purchased from Nomura Securities Co.,
Ltd., but the number may fluctuate when accounting for adjustment transactions executed at a later date to ensure that the Company's actual purchase price will be equal to the average price of the Company's share over a certain period. For details, please refer to the Company's press release dated May 15, 2026 entitled "Notice Regarding Acquisition of Own Shares and Acquisition of Own Shares through the Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) (Acquisition of Own Shares Pursuant to Article 459, Paragraph 1 of the Companies Act and Provisions of the Articles of Incorporation and Acquisition of Own Shares through Fully Committed ShareRepurchase (Japanese ASR))".
(Reference) Overview of the resolution on acquisition of own shares (announced May 15, 2026)
(1) | Type of stock acquired | Common stock |
(2) | Total number of shares to be acquired | 6,307,800 shares (Ratio to the total number of outstanding shares (excluding treasury shares): 3.5%) |
(3) | Total acquisition value of shares | JPY14,999,948,400 |
The Alfresa Group is a leader in the Japanese healthcare industry and is dedicated to making its corporate philosophy, "we create and deliver a fresh life for all," come true through a wide range of business lines, including ethical pharmaceuticals wholesaling, OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, operating dispensing pharmacies, regenerative medicine-related business, and CRO business. Alfresa Holdings Corporation (TSE:2784) reported consolidated revenue of ¥3.1 trillion for the fiscal year ended March 31, 2026. For more information, please see: https://www.alfresa.com/eng/
of own shares through off-auction own share repurchase trading system (ToSTNeT-3). It is not intended in any way to be an investment solicitation or serve any other similar purposes.